vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Sprinklr, Inc. is the larger business by last-quarter revenue ($219.1M vs $142.0M, roughly 1.5× Oncology Institute, Inc.). Sprinklr, Inc. runs the higher net margin — 1.3% vs -5.3%, a 6.6% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 9.2%). Sprinklr, Inc. produced more free cash flow last quarter ($19.8M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CXM vs TOI — Head-to-Head

Bigger by revenue
CXM
CXM
1.5× larger
CXM
$219.1M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+32.4% gap
TOI
41.6%
9.2%
CXM
Higher net margin
CXM
CXM
6.6% more per $
CXM
1.3%
-5.3%
TOI
More free cash flow
CXM
CXM
$17.6M more FCF
CXM
$19.8M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
TOI
TOI
Revenue
$219.1M
$142.0M
Net Profit
$2.9M
$-7.5M
Gross Margin
66.4%
Operating Margin
5.3%
-4.9%
Net Margin
1.3%
-5.3%
Revenue YoY
9.2%
41.6%
Net Profit YoY
-72.2%
43.0%
EPS (diluted)
$0.01
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
TOI
TOI
Q4 25
$219.1M
$142.0M
Q3 25
$212.0M
$136.6M
Q2 25
$205.5M
$119.8M
Q1 25
$202.5M
$104.4M
Q4 24
$200.7M
$100.3M
Q3 24
$197.2M
$99.9M
Q2 24
$196.0M
$98.6M
Q1 24
$194.2M
$94.7M
Net Profit
CXM
CXM
TOI
TOI
Q4 25
$2.9M
$-7.5M
Q3 25
$12.6M
$-16.5M
Q2 25
$-1.6M
$-17.0M
Q1 25
$98.7M
$-19.6M
Q4 24
$10.5M
$-13.2M
Q3 24
$1.8M
$-16.1M
Q2 24
$10.6M
$-15.5M
Q1 24
$21.1M
$-19.9M
Gross Margin
CXM
CXM
TOI
TOI
Q4 25
66.4%
Q3 25
68.2%
Q2 25
69.5%
Q1 25
71.0%
Q4 24
71.2%
Q3 24
72.6%
Q2 24
73.9%
Q1 24
75.5%
Operating Margin
CXM
CXM
TOI
TOI
Q4 25
5.3%
-4.9%
Q3 25
7.7%
-5.9%
Q2 25
-0.9%
-9.4%
Q1 25
5.2%
-9.5%
Q4 24
3.9%
-11.9%
Q3 24
-0.0%
-13.9%
Q2 24
2.9%
-16.6%
Q1 24
9.5%
-19.0%
Net Margin
CXM
CXM
TOI
TOI
Q4 25
1.3%
-5.3%
Q3 25
5.9%
-12.1%
Q2 25
-0.8%
-14.2%
Q1 25
48.7%
-18.8%
Q4 24
5.2%
-13.1%
Q3 24
0.9%
-16.1%
Q2 24
5.4%
-15.7%
Q1 24
10.9%
-21.0%
EPS (diluted)
CXM
CXM
TOI
TOI
Q4 25
$0.01
$-0.04
Q3 25
$0.05
$-0.14
Q2 25
$-0.01
$-0.15
Q1 25
$0.35
$-0.21
Q4 24
$0.04
$-0.14
Q3 24
$0.01
$-0.18
Q2 24
$0.04
$-0.17
Q1 24
$0.07
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$189.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$558.1M
$-15.7M
Total Assets
$1.1B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
TOI
TOI
Q4 25
$189.6M
Q3 25
$125.4M
Q2 25
$126.4M
Q1 25
$145.3M
Q4 24
$93.2M
Q3 24
$119.1M
Q2 24
$126.8M
$9.9M
Q1 24
$164.0M
$29.8M
Stockholders' Equity
CXM
CXM
TOI
TOI
Q4 25
$558.1M
$-15.7M
Q3 25
$543.4M
$-12.3M
Q2 25
$639.8M
$-9.0M
Q1 25
$612.1M
$5.1M
Q4 24
$497.0M
$3.6M
Q3 24
$469.0M
$15.5M
Q2 24
$610.9M
$29.2M
Q1 24
$679.7M
$41.3M
Total Assets
CXM
CXM
TOI
TOI
Q4 25
$1.1B
$164.7M
Q3 25
$1.1B
$163.6M
Q2 25
$1.2B
$159.8M
Q1 25
$1.2B
$164.0M
Q4 24
$970.3M
$172.7M
Q3 24
$983.8M
$179.2M
Q2 24
$1.1B
$179.6M
Q1 24
$1.2B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
TOI
TOI
Operating Cash FlowLast quarter
$20.0M
$3.2M
Free Cash FlowOCF − Capex
$19.8M
$2.2M
FCF MarginFCF / Revenue
9.0%
1.5%
Capex IntensityCapex / Revenue
0.1%
0.7%
Cash ConversionOCF / Net Profit
6.87×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
TOI
TOI
Q4 25
$20.0M
$3.2M
Q3 25
$34.8M
$-12.6M
Q2 25
$83.8M
$-10.2M
Q1 25
$5.4M
$-5.0M
Q4 24
$9.2M
$4.2M
Q3 24
$21.3M
$819.0K
Q2 24
$41.7M
$-15.7M
Q1 24
$17.3M
$-15.9M
Free Cash Flow
CXM
CXM
TOI
TOI
Q4 25
$19.8M
$2.2M
Q3 25
$34.4M
$-13.2M
Q2 25
$83.5M
$-11.4M
Q1 25
$4.6M
$-5.3M
Q4 24
$8.2M
$2.4M
Q3 24
$19.8M
$417.0K
Q2 24
$39.2M
$-17.5M
Q1 24
$15.2M
$-16.5M
FCF Margin
CXM
CXM
TOI
TOI
Q4 25
9.0%
1.5%
Q3 25
16.2%
-9.7%
Q2 25
40.6%
-9.5%
Q1 25
2.3%
-5.1%
Q4 24
4.1%
2.4%
Q3 24
10.1%
0.4%
Q2 24
20.0%
-17.7%
Q1 24
7.9%
-17.4%
Capex Intensity
CXM
CXM
TOI
TOI
Q4 25
0.1%
0.7%
Q3 25
0.2%
0.4%
Q2 25
0.1%
1.0%
Q1 25
0.4%
0.3%
Q4 24
0.5%
1.8%
Q3 24
0.8%
0.4%
Q2 24
1.3%
1.9%
Q1 24
1.1%
0.6%
Cash Conversion
CXM
CXM
TOI
TOI
Q4 25
6.87×
Q3 25
2.76×
Q2 25
Q1 25
0.05×
Q4 24
0.88×
Q3 24
11.58×
Q2 24
3.92×
Q1 24
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons